P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
0.197
+0.009 (4.72%)
At close: Dec 20, 2024, 4:00 PM
0.209
+0.012 (6.13%)
After-hours: Dec 20, 2024, 7:57 PM EST

P3 Health Partners Stock Forecast

PIII's stock price has decreased by -82.99% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for P3 Health Partners stock have an average target of 2.38, with a low estimate of 0.25 and a high estimate of 4.50. The average target predicts an increase of 1,106.28% from the current stock price of 0.20.

Analyst Consensus: Buy
Target Low Average Median High
Price $0.25 $2.38 $4.50 $4.50
Change +26.71% +1106.3% +2180.8% +2180.8%
* Price targets were last updated on Nov 20, 2024.

Analyst Ratings

The average analyst rating for PIII stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 111111
Buy 000000
Hold 222222
Sell 000000
Strong Sell 000000
Total 333333

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
TD Cowen
TD Cowen
Hold
Maintains
$0.9$0.25
Hold Maintains $0.9$0.25 +26.71% Nov 20, 2024
BTIG
BTIG
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Apr 1, 2024
Lake Street
Lake Street
Strong Buy
Maintains
$9$4.5
Strong Buy Maintains $9$4.5 +2,180.79% Mar 14, 2024
BTIG
BTIG
Strong Buy
Initiates
$5
Strong Buy Initiates $5 +2,434.21% Sep 1, 2023
TD Cowen
TD Cowen
Hold
Initiates
n/a
Hold Initiates n/a n/a Jun 30, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
1.54B
from 1.27B
Increased by 21.45%
Revenue Next Year
1.52B
from 1.54B
Decreased by -1.17%
EPS This Year
-0.66
from -0.63
EPS Next Year
-0.40
from -0.66
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
145.48M491.06M637.36M1.05B1.27B1.54B1.52B2.01B
Revenue Growth
-237.54%29.79%64.66%20.67%21.45%-1.17%32.24%
EPS
-0.88-0.48-0.24-6.50-0.63-0.66-0.40-0.43
EPS Growth
--------
Forward PE
--------
No. Analysts -----773
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 1.6B 1.8B 2.1B
Avg 1.5B 1.5B 2.0B
Low 1.5B 1.3B 1.9B

Revenue Growth

Revenue Growth 202420252026
High
26.0%
16.1%
36.1%
Avg
21.4%
-1.2%
32.2%
Low
15.7%
-12.7%
27.0%

EPS Forecast

EPS 202420252026
High -0.59 -0.22 -0.44
Avg -0.66 -0.40 -0.43
Low -0.72 -0.64 -0.41

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.